4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-24-006767
Chief Scientific Officer sold 20,000 shares at $9.50 ($190,000)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bellon Steven F. Chief Scientific Officer | 2024-09-09 | Sale 10b5-1 | −20,000 | $9.50 | $190,000 | 101,957 | D |
| Open-market sales · 20,000 sh · avg $9.50 · $190,000 | |||||||
Loading xslF345X05/primarydocument.xml…